TABLE VI.
Clinical characteristics for trajectory subtypes with max KDIGO 3/3D.
| - | 3Im | 3Im-1 | 3St | 3DSt | 3Ws | 3DWs |
|---|---|---|---|---|---|---|
|
| ||||||
| Count | 133 | 163 | 586 | 752 | 61 | 118 |
| Inpatient Mortality - n (%) | 9 (6.77) | 28 (17.18) | 176 (30.03) | 330 (43.88) | 42 (68.85) | 90 (76.27) |
| Demographics | ||||||
| Age - mean(SD) | 55.0 (12.5) | 61.4 (16.4) | 60.1 (16.0) | 55.1 (14.7) | 59.1 (15.4) | 55.2 (16.0) |
| Gender - male n(%) | 67 (50.4) | 79 (48.5) | 308 (52.6) | 427 (56.8) | 40 (65.6) | 79 (66.9) |
| Ethnic group - white n(%) | 119 (89.5) | 149 (91.4) | 543 (92.7) | 713 (94.8) | 57 (93.4) | 111 (94.1) |
| BMI - mean(SD) | 32.2 (10.7) | 31.7 (9.3) | 32.4 (12.8) | 34.1 (12.2) | 29.6 (7.9) | 29.8 (10.3) |
| Acuity of Critical Illness | ||||||
| SOFA score - median[IQ1 - IQ3] | 9.0 (7.0– 12.0) | 10.0 (8.0– 12.5) | 10.0 (8.0– 12.0) | 12.0 (10.0– 14.0) | 9.0 (7.0– 11.0) | 11.0 (9.0– 13.0) |
| APACHE score - median[IQ1 - IQ3] | 25.0 (22.0– 29.0) | 27.0 (24.0– 30.0) | 26.0 (22.0– 30.0) | 29.0 (25.0– 32.0) | 25.0 (22.0– 30.0) | 27.5 (23.0– 31.0) |
| AKI characteristics | ||||||
| ALL Baseline SCr - median[IQ1 - IQ3] | 0.9 (0.8– 1.0) | 0.9 (0.8– 1.0) | 0.9 (0.8– 1.0) | 1.0 (0.8– 1.1) | 1.0 (0.8– 1.0) | 1.0 (0.9– 1.1) |
| ALL Baseline eGFR - median[IQ1 - IQ3] | 74.5 (55.3– 74.6) | 74.6 (55.3– 74.6) | 65.1 (55.3– 74.6) | 55.3 (55.3– 74.6) | 55.3 (55.3– 74.6) | 55.3 (55.3– 74.5) |
| Measured Baselines - n (%) | 33 (24.8) | 34 (20.9) | 135 (23.0) | 185 (24.6) | 12 (19.7) | 39 (33.1) |
| Measured Baseline SCr - median[IQ1 - IQ3] | 0.8 (0.6– 1.0) | 0.7 (0.6– 0.9) | 0.8 (0.7– 1.0) | 1.0 (0.8– 1.4) | 0.8 (0.7– 0.9) | 1.2 (0.9– 1.5) |
| Measured Baseline eGFR - median[IQ1 - IQ3] | 77.7 (64.3– 97.4) | 83.3 (59.5– 105.0) | 73.7 (57.3– 90.7) | 56.0 (36.7– 76.2) | 74.4 (59.8– 81.7) | 48.8 (35.7– 71.3) |
| Imputed Baseline SCr - median[IQ1 - IQ3] | 1.0 (0.8– 1.0) | 0.9 (0.8– 1.0) | 1.0 (0.8– 1.0) | 1.0 (0.8– 1.0) | 1.0 (0.8– 1.0) | 1.0 (0.9– 1.1) |
| Imputed Baseline eGFR - median[IQ1 - IQ3] | 55.3 (55.3– 74.6) | 61.5 (55.3– 74.6) | 55.3 (55.3– 74.6) | 55.3 (55.3– 74.6) | 55.3 (55.3– 74.6) | 55.3 (55.3– 74.6) |
| Admit SCr - median[IQ1 - IQ3] | 3.4 (2.8– 4.4) | 3.3 (2.6– 4.3) | 2.7 (1.9– 3.9) | 3.1 (1.9– 4.6) | 1.2 (0.8– 1.6) | 1.4 (1.2– 1.9) |
| Peak SCr - median[IQ1 - IQ3] | 3.5 (2.8– 4.5) | 3.6 (2.9– 4.4) | 4.2 (3.4– 5.5) | 4.6 (3.3– 6.3) | 3.9 (3.2– 5.0) | 3.1 (2.4– 4.5) |
| Maximum KDIGO Stage - Whole ICU: | ||||||
| Stage 1 - n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Stage 2 - n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Stage 3 - n (%) | 132 (11.7) | 158 (14.0) | 530 (47.1) | 0 (0.0) | 49 (4.4) | 0 (0.0) |
| Stage 3D - n (%) | 1 (0.1) | 5 (0.5) | 56 (5.3) | 752 (70.9) | 12 (1.1) | 118 (11.1) |
| Maximum KDIGO Stage – 7 Days: | ||||||
| Stage 1 - n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Stage 2 - n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Stage 3 - n (%) | 133 (11.9) | 161 (14.4) | 570 (51.0) | 0 (0.0) | 57 (5.1) | 0 (0.0) |
| Stage 3D - n (%) | 0 (0.0) | 2 (0.2) | 16 (1.8) | 752 (83.7) | 4 (0.4) | 118 (13.1) |
| Urine output D0-D2 - median[IQ1 - IQ3] | 2.2 (1.6– 3.6) | 1.7 (1.0– 2.9) | 1.2 (0.6– 2.1) | 0.4 (0.1– 1.1) | 1.3 (1.0– 2.8) | 0.8 (0.3– 1.7) |
| Urine flow D0-D2 - median[IQ1 - IQ3] | 1.0 (0.7– 1.9) | 0.8 (0.5– 1.6) | 0.5 (0.3– 1.1) | 0.2 (0.1– 0.5) | 0.5 (0.4– 1.0) | 0.3 (0.1– 0.7) |